Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-21

Clinical Trial Update: Evaluation of Exparel Adductor Canal Field Block for Pain Control After ACL Reconstruction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Exparel adductor canal block for pain control after ACL reconstruction; status not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Carilion Clinic | Conditions: Anterior Cruciate Ligament Tear, Pain, Postoperative | Phase 3 | Status: UNKNOWN